13 nov. L’hépatite virale constitue un problème de santé publique international, comparable à celui posé par d’autres grandes maladies transmissibles. VIH, hépatites virales et comorbidités: épidémiologie clinique et santé era: Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS) CO3 . 29 nov. L’hépatite A est surveillée en France par la déclaration obligatoire . /Hepatites- virales/Hepatite-A/Comment-signaler-et-notifier-cette-maladie.
|Published (Last):||13 June 2007|
|PDF File Size:||1.34 Mb|
|ePub File Size:||19.1 Mb|
|Price:||Free* [*Free Regsitration Required]|
Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: Scand J Infect Dis. The challenge of geriatric patients.
Discussion:Hépatite virale — Wikipédia
Which antiretrovirals should be prescribed as first-line treatments? Mandibular osteonecrosis and dental exfoliation after trigeminal zoster in an HIV-infected patient. Aging, behavioral factors but not cART in a cross-sectional study. Long-term efficacy and safety of etravirine-containing regimens in a real-life cohort of treatment-experienced HIVinfected patients. Impact on tenofovir trough concentrations and renal safety.
Antiretroviral therapy as a risk factor for chronic kidney disease: Mean cost of a first combination antiretroviral therapy in HIV-infected patients in France, and determinants of expensive drugs prescription. What’s new in ? Erythrocyte and plasma ribavirin concentrations in the assessment of early and sustained virological responses to pegylated interferon-alpha 2a and ribavirin in patients coinfected with hepatitis C virus and HIV.
Risk factors of chronic kidney disease in HIV-infected patients. Impact on Tenofovir Ctrough but not on Renal Safety? Efficacy and tolerability of Etravirine in HIV-1 adult patients: Infection par le VIH et parcours de soin: Antiretroviral exposure and comorbidities in an aging HIV-infected population: Impact of tenofovir trough concentration.
No relationship between late HIV diagnosis and social deprivation in newly diagnosed patients in France. Clin J Am Soc Nephrol. Eur J Clin Pharmacol.
Hépatites virales B et C
Frailty in HIV infected people: Can the “seek, test, treat, and retain” strategy be effective in France? Risk factors associated with overweight and obesity in HIV-infected people: Hepatitis E virus infection in patients infected with the human immunodeficiency virus.
Results from a French prospective cohort.
Consequences on Chemotherapy Efficiency and Safety. HIV, co-morbidities and co-medications. J Acquir Hepatitfs Defic Syndr. HIV is associated with airway obstruction: Efficacy and safety of dolutegravir and rilpivirine dual therapy as 1 a simplification.
Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV-hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapy. Eur J Gastroenterol Hepatol. Formulaire de recherche Recherche.
Linked in Viadeo Youtube Email. A Cross- Sectional Analysis. Facebook Twitter Google Plus fr en du ar it sp. HIV-1 infection and first line ART induced differential responses in mitochondria from blood lymphocytes and monocytes: Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 hepatutes Cancer risk in HIV-infected patients: Relapse of hepatitis C virus after 14 months of sustained virological response following pegylated-interferon alpha plus ribavirin therapy in a human immunodeficiency virus type 1 infected patient.
Br J Clin Pharmacol.
Human vitales virus infection and non-small cell lung cancer: The spectrum of malignancies in HIV-infected patients in in France: Renal impairment in patients receiving a tenofovir-cART regimen: Results from traditional regression modeling and causal approach in a large observational study. An undetectable polymerase chain reaction signal in routine HIV plasma viral load monitoring is associated with better virological outcomes in patients receiving highly active antiretroviral therapy.
J Med Virol